The changing prevalence of comorbidity across the age spectrum.
about
Adjuvant treatment for older women with invasive breast cancerAssessing progress in reducing the burden of cancer mortality, 1985-2005.Identifying important comorbidity among cancer populations using administrative data: Prevalence and impact on survival.Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis.Hematopoietic stem cell transplantation for hematologic malignancies in older adults: geriatric principles in the transplant clinic.Can patient comorbidities be included in clinical performance measures for radiation oncology?The hip fracture incidence curve is shifting to the right.Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in the Dutch population using health survey data.A Nationwide Assessment of the Burden of Urinary Tract Infection among Renal Transplant Recipients.Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity scoreImpact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the Nationwide Inpatient Sample.A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions.Comparison of Scoring Methods for ACE-27: Simpler Is Better.Age-adjusted Charlson comorbidity index scores as predictor of survival in colorectal cancer patients who underwent surgical resection and chemoradiation.Impact of comorbidity on the outcome in men with advanced prostate cancer treated with docetaxel.Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer.Survival and Toxicity After Cisplatin Plus Etoposide Versus Carboplatin Plus Etoposide for Extensive-Stage Small-Cell Lung Cancer in Elderly Patients.Comorbidity and survival of Danish patients with colon and rectal cancer from 2000-2011: a population-based cohort study.Cost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-Medicare.Comorbidity in adult bone sarcoma patients: a population-based cohort studyImplication of comorbidity on the initiation of chemotherapy and survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma.The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy.Ablative surgery and free flap reconstruction for elderly patients with oral or oropharyngeal cancer: oncologic and functional outcomes.Predictors for dose reduction of antiviral therapy in older patients infected with hepatitis C virus: a meta-regression analysis.Assessment of comorbidities in surgical oncology outcomes.Comorbid conditions associated with glioblastoma.High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma.Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation.Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.Machine learning approaches to personalize early prediction of asthma exacerbations.Comorbidity and the risk of anastomotic leak in Chinese patients with colorectal cancer undergoing colorectal surgery.Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning.The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.Predicting the need for end-of-life care for elderly cancer patients: findings from a Dutch regional cancer registry database.Competing Risks for Mortality in Patients With Asymptomatic Pancreatic Cystic Neoplasms: Implications for Clinical Management.Excess mortality in the myelodysplastic syndromes.Primary radical ablative surgery and fibula free-flap reconstruction for T4 oral cavity squamous cell carcinoma with mandibular invasion: oncologic and functional results and their predictive factors.Role of comorbidities in optimizing decision-making for allogeneic hematopoietic cell transplantation.A cross-sectional analysis of the association between age and gender and prescribed minimum benefit chronic disease list conditions among South Africans with concomitant hypertension, diabetes and dyslipidaemia[Psychological comorbidity in elderly patients with cancer].
P2860
Q28066744-937C29BD-250F-4611-89BA-58B5A1A50313Q30570624-13C72890-536E-4FFC-8EED-49078F7F44D9Q30719268-46C4B502-A3FE-4347-839F-D346ED1B0F4FQ33443629-922BBC30-27D7-4DC8-9CF6-2513A84ED1ADQ33566684-D3009168-1D09-409B-9865-E3D672E03999Q33600092-C3FEEB0D-9566-4C69-ADB7-FF14739C31FDQ33660904-80087E5C-F705-4B44-A552-38370D78408BQ34008014-5AC08A24-F6FE-4D9B-B327-0080F66E41C4Q35165248-D292C4B2-3A11-4514-B820-B1DB18DF78F1Q35664302-8B521E4B-F52E-4A9C-89F1-94286672ECC4Q35678927-3B94097C-D2E8-40CC-AEFC-767ACDFD3CACQ35973551-8D352F90-3ADE-4424-B858-086BF5A0AFA7Q36034146-6DA4FCF1-8DC6-412B-B3CE-6CD3A2FA24A8Q36151471-3623F541-65F7-4EA4-B720-9A66B316F26EQ36490409-968DCE9A-D478-4FB5-8260-292701C652A2Q37065671-C25C2AF4-E9E9-4226-835B-0DC9803225B8Q37117864-5CC6FFDB-6945-4C5D-8A9F-B1340187754AQ37288177-AADC7DBF-560B-415E-AC14-FA1FA6DE7051Q37382627-46934024-08BE-4E80-8856-AC3641D12AEAQ37644999-2E6ECF10-9D00-40A0-91AF-64B01FBDB559Q37705880-375D9C8F-8EFA-48B9-80E9-A8661CA96402Q37724712-756B823A-3C43-4DA9-8732-FC34E4E7E6E3Q37893157-C207C9FF-72F0-48F9-AE46-932ED7DFE4F4Q38160178-B75E3041-A9A1-4CA3-8B46-95147EF170C9Q38237623-ABFA331D-3807-4884-8BA1-F47B90AA2BC2Q38422801-FF8E16BE-D16F-4652-AEBA-FC0162353B45Q38552083-247014B9-BE37-4CC1-9CA0-1E9078C7DD4FQ38698528-8D938757-F1CA-4506-A8E0-AD97DCB4AABDQ38699712-847DACE7-FBF9-4654-9844-CB50784F9731Q38821380-2FE63001-4A27-4074-9964-D51CEF383574Q38880578-D1DBC2ED-83FC-45D8-90D4-4561A53B189DQ38960040-96CB145B-AA8E-45E9-A8DB-03FCD692C274Q39485233-856D0674-E7F2-46B0-8703-E2D99AED4554Q39673427-26A7CD2B-3083-40F5-AC40-09687EE5E38AQ40189653-B474C088-46DF-45EF-9062-0035393A1977Q40470007-0E03F5AC-6D79-4AA1-A530-18EE16680D7EQ40641801-953D1BEF-DE31-42CE-B734-B1B9F7C1F723Q41191932-F1B35C0E-8C7B-4BC8-89F8-E9C053C6DB96Q42223627-646FB40A-08B0-4F9F-9586-638BA14B4107Q43543834-B70B1532-7816-4FAF-AE10-5D7399C5E868
P2860
The changing prevalence of comorbidity across the age spectrum.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The changing prevalence of comorbidity across the age spectrum.
@en
type
label
The changing prevalence of comorbidity across the age spectrum.
@en
prefLabel
The changing prevalence of comorbidity across the age spectrum.
@en
P2093
P2860
P1476
The changing prevalence of comorbidity across the age spectrum.
@en
P2093
Anna Vlahiotis
Edward L Spitznagel
Jay F Piccirillo
Kellie L Flood
Laurel B Barrett
P2860
P304
P356
10.1016/J.CRITREVONC.2008.01.013
P577
2008-03-28T00:00:00Z